nyxthracis (previously obiltoxaximab sfl)
sfl pharmaceuticals deutschland gmbh - nyxthracis - anthrax - imunitný séra a imunoglobulíny, - obiltoxaximab sfl is indicated in combination with appropriate antibacterial drugs in all age groups for treatment of inhalational anthrax due to bacillus anthracis (see section 5. obiltoxaximab sfl is indicated in all age groups for post-exposure prophylaxis of inhalational anthrax when alternative therapies are not appropriate or are not available (see section 5.
medicinálny kyslík plynný sol 100 % medicinálny plyn, stlačený
sol spa, taliansko - kyslík - 87 - varia i
imprida
novartis europharm ltd - valsartan, amlodipine (as amlodipine besilate) - vysoký tlak - Činidlá pôsobiace na systém renín-angiotenzín - liečba esenciálnej hypertenzie. imprida je indikovaný u pacientov, ktorých krvný tlak nie je primerane kontrolované na amlodipine alebo valsartan monotherapy.
ciprolon 200 mg/100 ml
hikma farmaceutica (portugal) s.a., portugalsko - ciprofloxacín - 42 - chemotherapeutica (vratane tuberkulostatik)
cloxalene plus 200 mg + 200 mg/5 ml intramammárna masť
fatro s.p.a., taliansko - ung.
rometar 20 mg/ml injekčný roztok
bioveta, Česká republilka - inj.
ciprinol
krka, d.d., novo mesto, slovinsko - ciprofloxacín - 42 - chemotherapeutica (vratane tuberkulostatik)
ciprinol 250
krka, d.d., novo mesto, slovinsko - ciprofloxacín - 42 - chemotherapeutica (vratane tuberkulostatik)